focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 30 April 2015

29 May 2015 07:05

RNS Number : 5721O
Standard Life Euro Pri Eqty Tst PLC
29 May 2015
 

29 May 2015

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 30 APRIL 2015

· ESTIMATED NAV AT 30 APRIL 2015 WAS 269.9 PENCE PER SHARE (NAV AT 31 MARCH 2015 WAS 268.6 PENCE PER SHARE)

· SLEPET RECEIVED £12.3 MILLION OF DISTRIBUTIONS AND PAID £1.0 MILLION OF DRAW DOWNS DURING THE MONTH OF APRIL

· SLEPET HAD £270.1 MILLION OF OUTSTANDING COMMITMENTS AT 30 APRIL 2015

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which SLEPET has holdings. In the case of SLEPET's valuation at 30 April 2015, 100% of the reported portfolio valuations were dated 31 March 2015.

 

Estimated NAV

At 30 April 2015, SLEPET's estimated NAV was 269.9 pence per share (estimated net assets £424.6 million), representing a 0.5% per share increase from the NAV at 31 March 2015 of 268.6 pence per share (net assets £422.5 million).

 

Draw downs and distributions

SLEPET paid £1.0 million of draw downs and received £12.3 million of distributions during the month. The distributions received generated net realised gains and income of £6.9 million.

 

Commitments

A new commitment of €30.0 million was made to Equistone Partners Europe Fund V in April. The Company had £270.1 million of outstanding commitments at 30 April 2015. After undertaking a detailed review, the Manager continues to believe that up to £50 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had liquid resources of £58.4 million at 30 April 2015, comprising a cash balance of £26.7 million and £31.7 million invested at value (£29.5 million at cost) in UK and European equity index tracker funds. The Company has an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 May 2015 on or around 12 June 2015.

 

 

 

 

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the latest monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVPGUPGAUPAGMR
Date   Source Headline
20th Jul 20154:33 pmRNSTransaction in Own Shares
14th Jul 20157:00 amRNSEstimated NAV at 30 June 2015
9th Jul 201512:59 pmRNSTransaction in Own Shares
9th Jul 201512:51 pmRNSHolding(s) in Company
7th Jul 201510:37 amRNSTransaction in Own Shares
1st Jul 20154:56 pmRNSTransaction in Own Shares
1st Jul 20158:00 amRNSQuarterly Disclosure
1st Jul 20158:00 amRNSTotal Voting Rights
30th Jun 20155:16 pmRNSTransaction in Own Shares
29th Jun 20154:55 pmRNSTransaction in Own Shares
26th Jun 20154:58 pmRNSTransaction in Own Shares
25th Jun 20154:39 pmRNSTransaction in Own Shares
17th Jun 20159:41 amRNSTransaction in Own Shares
12th Jun 20154:37 pmRNSTransaction in Own Shares
12th Jun 20157:00 amRNSEstimated NAV at 31 May 2015
9th Jun 20154:57 pmRNSTransaction in Own Shares
5th Jun 201512:45 pmRNSTransaction in Own Shares
29th May 20157:05 amRNSEstimated NAV at 30 April 2015
29th May 20157:00 amRNSHalf Yearly Report
16th Apr 20157:00 amRNSEstimated NAV at 31 March 2015
1st Apr 201510:00 amRNSQuarterly Disclosure
19th Mar 20157:01 amRNSEstimated NAV at 28 February 2015
19th Mar 20157:00 amRNSQuarterly Trading Statement
2nd Mar 20157:30 amRNSTotal Voting Rights
27th Feb 20155:04 pmRNSHolding(s) in Company
16th Feb 20157:00 amRNSEstimated NAV at 31 January 2015
12th Feb 20159:21 amRNSTransaction in Own Shares
10th Feb 20154:55 pmRNSTransaction in Own Shares
4th Feb 20155:14 pmRNSTransaction in Own Shares
2nd Feb 20159:33 amRNSTotal Voting Rights
30th Jan 20155:04 pmRNSTransaction in Own Shares
28th Jan 20152:32 pmRNSInterim Management Statement
28th Jan 20152:26 pmRNSResult of AGM
9th Jan 201510:31 amRNSHolding(s) in Company
2nd Jan 20159:10 amRNSQuarterly Disclosure
8th Dec 20147:00 amRNSPreliminary Results
3rd Nov 20149:36 amRNSTotal Voting Rights
8th Oct 20144:14 pmRNSTransaction in Own Shares
7th Oct 201411:44 amRNSTransaction in Own Shares
7th Oct 20149:19 amRNSDirector/PDMR Shareholding
1st Oct 20143:35 pmRNSQuarterly Disclosure
1st Oct 20143:33 pmRNSTotal Voting Rights
26th Sep 201411:55 amRNSTransaction in Own Shares
24th Sep 20141:15 pmRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSQuarterly Trading Statement
31st Jul 20142:06 pmRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSInterim Management Statement
1st Jul 20149:00 amRNSQuarterly Disclosure
30th May 20147:00 amRNSHalf Yearly Report
28th May 20143:20 pmRNSDirectorate Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.